Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
株式のランク #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
株価
$0.11725176
最終同期: 2025-07-14
時価総額
$481.50K
変化(1日)
-0.20%
変化(1年)
0.00%
FR
取引 PHAXIAM Therapeutics S.A. (PHXM)

カテゴリー

PHAXIAM Therapeutics S.A.(PHXM)の株式分割履歴
PHAXIAM Therapeutics S.A.株(シンボル:PHXM)は合計で2回の株式分割を実施しました。
最新の株式分割はJun 13, 2024に行われました。
Sep 18, 2023より前に購入されたPHXM株は、現在0.10819672131148PHXM株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2024-06-13 66:61 x1.0819672131148 x0.10819672131148
2023-09-18 1:10 x0.1 x0.1
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE